Y

YiChang HEC ChangJiang Pharmaceutical Co Ltd
HKEX:1558

Watchlist Manager
YiChang HEC ChangJiang Pharmaceutical Co Ltd
HKEX:1558
Watchlist
Price: 15.88 HKD Market Closed
Market Cap: HK$14B

Profitability Summary

YiChang HEC ChangJiang Pharmaceutical Co Ltd's profitability score is 53/100. We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

53/100
Profitability
Score

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

53/100
Profitability
Score
53/100
Profitability
Score

Margins

Earnings Waterfall
YiChang HEC ChangJiang Pharmaceutical Co Ltd

Margins Comparison
YiChang HEC ChangJiang Pharmaceutical Co Ltd Competitors

Country Company Market Cap Gross
Margin
Operating
Margin
Net
Margin
CN
YiChang HEC ChangJiang Pharmaceutical Co Ltd
HKEX:1558
14B HKD
Loading...
Loading...
Loading...
US
Eli Lilly and Co
NYSE:LLY
978.7B USD
Loading...
Loading...
Loading...
US
Johnson & Johnson
NYSE:JNJ
547.3B USD
Loading...
Loading...
Loading...
CH
Roche Holding AG
SIX:ROG
277.3B CHF
Loading...
Loading...
Loading...
UK
AstraZeneca PLC
LSE:AZN
210B GBP
Loading...
Loading...
Loading...
CH
Novartis AG
SIX:NOVN
220.8B CHF
Loading...
Loading...
Loading...
US
Merck & Co Inc
NYSE:MRK
273B USD
Loading...
Loading...
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.6T DKK
Loading...
Loading...
Loading...
IE
Endo International PLC
LSE:0Y5F
218B USD
Loading...
Loading...
Loading...
US
Pfizer Inc
NYSE:PFE
150.2B USD
Loading...
Loading...
Loading...
FR
Sanofi SA
PAR:SAN
96.4B EUR
Loading...
Loading...
Loading...

Return on Capital

Return on Capital Comparison
YiChang HEC ChangJiang Pharmaceutical Co Ltd Competitors

Country Company Market Cap ROE ROA ROCE ROIC
CN
YiChang HEC ChangJiang Pharmaceutical Co Ltd
HKEX:1558
14B HKD
Loading...
Loading...
Loading...
Loading...
US
Eli Lilly and Co
NYSE:LLY
978.7B USD
Loading...
Loading...
Loading...
Loading...
US
Johnson & Johnson
NYSE:JNJ
547.3B USD
Loading...
Loading...
Loading...
Loading...
CH
Roche Holding AG
SIX:ROG
277.3B CHF
Loading...
Loading...
Loading...
Loading...
UK
AstraZeneca PLC
LSE:AZN
210B GBP
Loading...
Loading...
Loading...
Loading...
CH
Novartis AG
SIX:NOVN
220.8B CHF
Loading...
Loading...
Loading...
Loading...
US
Merck & Co Inc
NYSE:MRK
273B USD
Loading...
Loading...
Loading...
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.6T DKK
Loading...
Loading...
Loading...
Loading...
IE
Endo International PLC
LSE:0Y5F
218B USD
Loading...
Loading...
Loading...
Loading...
US
Pfizer Inc
NYSE:PFE
150.2B USD
Loading...
Loading...
Loading...
Loading...
FR
Sanofi SA
PAR:SAN
96.4B EUR
Loading...
Loading...
Loading...
Loading...

Free Cash Flow

Free Cash Flow Analysis
YiChang HEC ChangJiang Pharmaceutical Co Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate